9780306477669-0306477661-Applications of Pharmacokinetic Principles in Drug Development

Applications of Pharmacokinetic Principles in Drug Development

ISBN-13: 9780306477669
ISBN-10: 0306477661
Edition: 2004
Author: Rajesh Krishna
Publication date: 2003
Publisher: Springer
Format: Hardcover 566 pages
FREE US shipping

Book details

ISBN-13: 9780306477669
ISBN-10: 0306477661
Edition: 2004
Author: Rajesh Krishna
Publication date: 2003
Publisher: Springer
Format: Hardcover 566 pages

Summary

Applications of Pharmacokinetic Principles in Drug Development (ISBN-13: 9780306477669 and ISBN-10: 0306477661), written by authors Rajesh Krishna, was published by Springer in 2003. With an overall rating of 4.4 stars, it's a notable title among other Agricultural Sciences (Biochemistry, Chemistry, Biology, Biological Sciences, General & Reference, Evolution, Chemistry, Pharmacology, Pharmacy, Pharmacology, Veterinary Medicine) books. You can easily purchase or rent Applications of Pharmacokinetic Principles in Drug Development (Hardcover) from BooksRun, along with many other new and used Agricultural Sciences books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.16.

Description

This volume is an important advancement in the application ofpharmacokinetic (PK) and pharmacodynamic (PO) principles to . drug development. The series of topics presented deal with the application of these tools to everyday decisions that a pharmaceutical scientist encounters. The ability to integrate these topics using PK and PO methods has optimized drug development pathways in the clinic. New technologies in the areas of in vitro assays that are more predictive of human absorption and metabolism and advancement in bioanalytical assays are leading the way to minimize drug failures in later, more expensive clinical development programs. of Pharmacokinetics and pharmacodynamics have become an important component understanding the drug action on the body and is becoming increasingly important in drug labeling due to it's potential for predicting drug behavior in populations that may be difficult to study in adequate numbers during drug development. The ability to correlate drug exposure to effect and model it during the drug development value chain provides valuable insight into optimizing the next steps to derive maximum information from each study. These principles and modeling techniques have resulted in an expanded and integrated view of PK and PO and have led to the expectations that we may be able to optimally design clinical trials and eventually lead us to identifying the optimal therapy for the patient, while minimizing cost and speeding up drug development. There is wide utility for the book both as a text and as a reference.

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book